Isomer Partners’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-40,000
Closed -$7.05M 18
2023
Q3
$7.05M Hold
40,000
3.66% 12
2023
Q2
$7.52M Buy
+40,000
New +$7.56M 3.77% 13
2021
Q1
Sell
-90,000
Closed -$16.6M 28
2020
Q4
$16.6M Buy
90,000
+35,000
+64% +$5.76M 2.71% 13
2020
Q3
$8.28M Buy
+55,000
New +$8.63M 1.99% 16

Other funds holding MSGS

Isomer Partners's MSGS Position: Q4 2023 in Review

Isomer Partners sold out of Madison Square Garden (MSGS) in Q4 2023, closing a stake of 40,000 shares — an estimated $7.05M sold.

Isomer Partners first reported a position in MSGS in Q3 2020 and held it in 4 quarters. The position peaked at $16.6M in Q4 2020. 293 funds tracked by Wall St. Rank hold MSGS as of Q4 2023.

  • Isomer Partners reported no remaining Madison Square Garden position as of Q4 2023 after selling out during the quarter.
  • Isomer Partners sold 40,000 Madison Square Garden shares in Q4 2023, an estimated $7.05M.
  • Isomer Partners first reported a position in Madison Square Garden in Q3 2020 and held it in 4 quarters.
  • Isomer Partners's Madison Square Garden position peaked at $16.6M in Q4 2020.
  • 293 funds tracked by Wall St. Rank held Madison Square Garden as of Q4 2023.

Based on Isomer Partners's 13F filing for Q4 2023, filed 14 Feb 2024.